Apr 10 |
Does Belite Bio (BLTE) Have the Potential to Rally 41.14% as Wall Street Analysts Expect?
|
Mar 22 |
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
|
Mar 20 |
Here's Why We're Not Too Worried About Belite Bio's (NASDAQ:BLTE) Cash Burn Situation
|
Mar 12 |
Belite Bio, Inc (BLTE) Q4 2023 Earnings Call Transcript
|
Mar 12 |
Belite Bio GAAP EPS of -$0.25 beats by $0.05
|
Mar 12 |
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
|
Mar 12 |
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
|
Mar 6 |
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
|
Mar 4 |
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference
|
Feb 7 |
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|